Parkinson's doesn't start in the brain? Shocking new study reveals the real origin
Image credits: Getty Images
Parkinson's disease (PD) is the second-most neurodegenerative disorder in the United States. According to the National Institute of Neurological Disorders and Stroke, as many as
1 million
Americans have Parkinson's Disease.
Until now it was believed that Parkinson's disease begins with a gradual loss of nerve cells in the brain, particularly those producing dopamine, a neurotransmitter vital for movement. This leads to a decline in dopamine levels leading to symptoms such as tremors, stiffness and slow movement.
Now, a new
study
published in Nature Neuroscience, suggests that the disease actually begins from a shocking body part- the kidneys.
The team of researchers from Wuhan University in China performed the study primarily focused on the alpha-synuclein (a-Syn) protein, which is closely associated with Parkinson's.
When the production of this protein becomes uneven, it creates clumps of misfolded proteins that interfere with brain function. As per the research, the clumps of this protein can develop in the kidneys as well and thus the researchers are of the belief that these abnormal proteins might actually travel from the kidneys to the brain, triggering the disease.
"We demonstrate that the kidney is a peripheral organ that serves as an origin of pathological α-Syn," wrote the researchers in the published paper.
The shocking study
Image credits: Getty Images
To carry out the study, the team ran multiple tests to analyse the behaviour of the protein in genetically engineered mice and human tissue that included samples from people with Parkinson's disease and chronic kidney disease.
The team found abnormal a-Syn growth in the kidneys of 10 out of 11 people with Parkinson's and other types of dementia related to Lewy bodies.
In another sample batch, similar protein malfunctions were found in 17 out of 20 patients with chronic kidney disease, even though these people had no signs of neurological disorders.
In animals, mice with healthy kidneys cleared out injected a-Syn clumps, but mice whose kidneys weren't functioning faced protein built-ups that eventually spread to the brain.
The study also analysed the fact that these proteins move through the blood and if they are reduced in the blood, the damage to the brain can be decreased. This point needs to be noted as an inspiration for new strategies of treatment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Parkinson's disease: NOT your brain; study reveals your ears might hold clues to early signs of the disease
Parkinson's disease is a progressive neurological disorder that primarily affects movement. It is characterized by the degeneration of nerve cells in the brain, specifically those producing dopamine, a neurotransmitter crucial for coordinating movement. This leads to a range of symptoms, including tremors, stiffness, and slowness of movement. While there is no cure, treatments and therapies can help manage symptoms and improve quality of life. Globally, Parkinson's disease (PD) affects millions. A study published in The BMJ in March 2025 projects that 25.2 million people will be living with Parkinson's by 2050. But what if we can detect Parkinson's disease with an easy hack? No scans, no invasive tests – imagine being able to early diagnose Parkinson's with a gentle swab of your ear. Recent research reveals that earwax – or cerumen – may carry subtle chemical signals pointing to Parkinson's disease (PD) long before traditional symptoms appear. By analyzing volatile organic compounds (VOCs) in earwax and feeding that data into artificial‑intelligence systems, scientists have achieved detection accuracy as high as 94%. This promising approach could offer an easy, non‑invasive, and cost‑effective screening method. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Read on to know more. What does the study say? The new research, published in Analytical Chemistry , has found that volatile organic compounds (VOCs) in earwax could carry chemical signals of the neurological disease. The work builds on earlier findings suggesting that Parkinson's subtly alters body odor, through changes in sebum, the oily substance that naturally moisturizes our hair and skin. The problem with trying to analyze sebum on the skin is that its exposure to air and the external environment makes it less reliable for clinical testing. Scientists led by a team from Zhejiang University wanted to take a look at earwax, which is better protected. The researchers took ear canal swabs from 209 study participants, 108 of whom had been given a Parkinson's disease diagnosis. By charting differences in earwax composition between people with and without Parkinson's, four VOCs stood out: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. As the researchers mentioned in their published paper, "Early diagnosis and intervention are crucial for Parkinson's disease treatment," adding, "This study proposes a diagnostic model… that analyzes VOCs from ear canal secretions." According to the scientists, those VOCs can be altered by inflammation, cell stress, and neurodegeneration in the brain. With the right tests, the team hypothesized that subtle signals for Parkinson's could show up in the ears. These could potentially be used to identify Parkinson's in the future, acting as a foundation around which tests can be developed. First, though, this same analysis needs to be run on larger groups of people over longer periods of time. Earwax: An unexpected diagnostic window Earwax, medically known as cerumen, is more than just debris – it contains sebum, an oily secretion from skin glands, along with waxy fatty acids and dead skin cells. Sebum's chemical composition reflects our skin's metabolic activity. Earlier studies found that people with Parkinson's often emit a distinctive musky odor, traced back to sebum on their skin, caused by inflammation, oxidative stress, and neurodegeneration. Yet, skin-mounted sebum exposed to pollution and humidity can muddy chemical signals. Enter the ear canal – a more protected environment. Wax from the ear canal remains sheltered, making it a more stable source for detecting sebum-based chemical markers. The findings: Four key VOCs The team, led by Hao Dong and Danhua Zhu at Zhejiang University, collected earwax samples from 209 participants –108 diagnosed with Parkinson's and 101 healthy controls. Using advanced separation techniques (gas chromatography–mass spectrometry and GC with surface acoustic wave sensors), they analyzed the chemical makeup of the samples. Out of hundreds of detected VOCs, four stood out – chemicals whose levels consistently differed in Parkinson's patients: Ethylbenzene 4‑Ethyltoluene Pentanal 2‑Pentadecyl‑1,3‑dioxolane Statistical analysis showed these chemicals were significantly altered in Parkinson's patients. These differences likely stem from underlying processes in Parkinson's: neurodegeneration, systemic inflammation, oxidative stress, and changes in fat metabolism. Enter AI – with 94% accuracy Detecting these VOCs is only one part of the equation – interpreting them demands precision. The researchers built an Artificial Intelligence Olfactory (AIO) system using two methods: A support‑vector machine trained on GC‑MS data. A convolutional neural network (CNN) trained on GC‑SAW sensor data. The CNN-AIO achieved 94–94.4% accuracy in differentiating Parkinson's from non-Parkinson's samples, with an impressive receiver‑operating‑characteristic (ROC) area under the curve (AUC) of ~0.98. This highlights the system's potential as a reliable early-screening tool – fast, inexpensive, non‑invasive, and amenable to low-resource medical settings. As per the researchers, "The AIO-based analytical system underscores its potential for use in bedside medical diagnostic devices, aiding in earlier and more effective treatment for Parkinson's disease patients." The findings could also help the ongoing study to understand how Parkinson's gets started and how it might be stopped. Identified VOC changes could possibly be used as a chemical fingerprint, identifying other changes happening because of – or perhaps leading to – the disease. Why early detection matters: Currently, Parkinson's is diagnosed based on motor symptoms – tremors, muscle rigidity, slowed movement – when significant neurological damage has already occurred. Conventional diagnostic methods, like brain imaging or dopamine transporter scans, are expensive, time-consuming, and not always precise Earlier detection through earwax offers three big benefits: Preventive timing: Intervene sooner to potentially slow disease progression and preserve quality of life. Accessibility: Ear swabs require minimal training and equipment, less costly than imaging. Consistency: Earwax sebum isn't easily contaminated, unlike skin sebum. An affordable, objective test could change the landscape for millions of people worldwide. What's ahead: The next steps? Wider trials across multiple centers and demographics to confirm whether this test is robust in varied populations and stages of Parkinson's, develop bedside protocols using rapid GC-SAW sensors and AI for real-time screening, and explore biological pathways linking VOC changes to cellular processes, which could illuminate PD's origins and potential therapeutic targets. Researchers Dr. Hao Dong and colleagues emphasize the need for multi-center trials, involving diverse ethnicities and disease stages, before real-world use. As per Dr. Dong, from the Nanjing University of Aeronautics and Astronautics, "The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value. " Speech may be clue to early mental decline
Mint
4 hours ago
- Mint
Is your brain aging faster than you? New science offers clues
Dan Jones of Cedar City, Utah, has resumed playing the bagpipes after lifestyle changes. Dan Jones liked his job as a quality-control inspector and loved his hobby even more: playing in a local bagpipe band. Then he started making mistakes in the pieces he played. He found himself having to write tasks down if he wanted to remember them. In 2021, at age 56, he was diagnosed with dementia. The future he had plotted with his wife, Darla, suddenly seemed to evaporate. 'We had lots of plans, and they all ended," he says. Jones packed up his bagpipes for good and moved to a work role that offered a more predictable schedule. Then his wife learned about a study testing whether lifestyle changes could reverse early-stage Alzheimer's disease. Enrolling meant Jones had to give up his favorite foods, like roast beef, homemade spaghetti and ice cream, for a plant-based diet with minimally processed foods that are low in refined carbs and sugars. He had to do more exercise, meditate daily and meet regularly with a support group. Several months into the study, Jones picked up his bagpipes again, and by July 2022 he was performing in a parade in his hometown of Cedar City, Utah. He stopped waking up confused about where he was while traveling. Cognitive assessments showed that aspects of his memory had stabilized or improved. 'You could not pay me to quit eating the way I eat now, or to quit doing the exercise," he says. 'It made that big a difference." Jones has adopted a plant-based diet with foods that are low in refined carbs and tries to meditate for 30 minutes most days of the week. Jones wasn't alone. The full study, published in 2024 and led by the nonprofit Preventive Medicine Research Institute, found that brain function and cognition significantly improved in patients who made lifestyle changes. As tools and tests that gauge brain health become more accessible, a growing body of research suggests we can actually do something about it. The research comes as the gap widens between lifespan and healthspan—the number of years spent in good health. Americans are living longer on average, leaving more time to develop age-related diseases including dementia. New cases of dementia will double by 2060 to roughly one million annually, according to a recent study, Dr. Dean Ornish, founder of the Preventive Medicine Research Institute, spent decades testing whether and how lifestyle changes could affect other diseases such as prostate cancer, heart disease and aspects of aging itself. For the Alzheimer's study that included Jones, Ornish and a team of researchers randomly assigned 51 participants to one of two groups: a control group with no lifestyle changes, or an intensive program. Patients were tested at baseline and retested after 4½ months. In a test measuring changes in brain function over time, 71% of patients who made lifestyle changes showed improvement or no deterioration in their condition. In the control group, none improved, and 68% got worse. The study's small sample size makes the findings difficult to generalize, according to Ornish, but the results show a big difference. 'The earlier you intervene, the less intensive the lifestyle changes likely need to be to prevent it," Ornish says. 'It's really giving new hope and new choices to people who didn't have that before." A separate study published in 2024 looked at healthy people. It found that even modest levels of physical activity, as low as 25 minutes of moderate to vigorous activity a week, are linked to bigger brain sizes—a marker for better brain health. Jones says increased exercise has contributed to his improved health. 'Lifestyle matters," says Rudolph Tanzi, a professor of neurology at Harvard Medical School and director of the McCance Center for Brain Health at Massachusetts General Hospital, who studies Alzheimer's disease genes and who worked on the study including Jones. Advances in diagnostic and prognostic tools are helping doctors and scientists gain new understanding of how to measure and modify cognitive function. Andrei Irimia, an associate professor at USC Leonard Davis School of Gerontology who has studied brain aging for more than a decade, co-developed an artificial-intelligence model that uses MRI scans to calculate how fast a patient's brain is aging relative to chronological age. The model takes into account variables linked to brain aging, such as the size of the hippocampus, which is involved in memory, and the thickness of the cortex, the brain's outermost layer. Irimia says the model can monitor in real time how the brain reacts to problems or improvements in lifestyle. A reminder list in Jones's home. Faster brain aging is linked to a higher risk of cognitive impairment, he says. In May, the Food and Drug Administration approved the first blood test to help diagnose Alzheimer's disease. It is designed for people who are already having memory problems, not healthy people without symptoms. Various companies are developing blood tests that would let anyone determine 'brain age." NeuroAge Therapeutics, a longevity biotech company, makes a $700 blood test that tracks dozens of RNA molecules. A more expensive package includes the blood test, a brain MRI, genetic testing, memory games and an analysis that offers a comprehensive brain-age score. NeuroAge was founded by Dr. Christin Glorioso, a neuroscientist. Glorioso carries one copy of the APOE4 gene, which carries an elevated risk of developing Alzheimer's, and she says she started putting a priority on sleep after seeing her results. There is a link between insufficient sleep and dementia risk. Many doctors and researchers say biological-age testing requires rigorous research and validation before it should be widely adopted. It is also expensive—many of the blood tests cost hundreds of dollars out of pocket, and elective MRIs can cost hundreds to thousands. 'I would be extremely cautious as a consumer, and I would want to see scientific evidence that whatever they measure is relevant," says Tony Wyss-Coray, a professor of neurology at Stanford University. His lab has developed a protein-based blood test to measure the ages of the brain and other organ systems. With refinement, these tools could one day make a big difference for patients like Dan Jones. 'The people who can know those things sooner have an advantage," says Jones, who adds that he didn't take any genetic or brain health-specific tests before his diagnosis. 'I would have made the changes a lot earlier. Write to Alex Janin at
Time of India
5 hours ago
- Time of India
US doctor reveals the BEST exercise to reverse fatty liver
Dr. Wendi LeBrett highlights weight-bearing exercises as crucial for preventing and improving fatty liver disease, a condition affecting millions. Prioritizing muscle building over cardio helps combat insulin resistance, a key factor in the disease's development. Exercises like walking, squats, and lunges, combined with a balanced diet low in refined sugars, are recommended. Fatty liver disease is a growing health concern, affecting millions of people across the globe. One of the most common types is metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD). Linked to poor diet, obesity, and sedentary lifestyle, this condition can lead to liver inflammation, scarring, and even cirrhosis if left untreated. Dr. Wendi LeBrett, a double-board-certified gastroenterologist and internal medicine physician based in California, has now shared an exercise that can help prevent and even improve fatty liver disease. Before we dive into that, let's take a look at fatty liver disease and its symptoms. What is fatty liver? The liver is the largest organ in the body, which helps the body to digest food, store energy, and remove toxins. Fatty liver disease is a condition where excess fat accumulates in the liver, impairing its function. There are two main types: Metabolic dysfunction-associated steatotic liver disease (MASLD), aka Nonalcoholic fatty liver disease (NAFLD) Alcoholic fatty liver disease, also called alcoholic steatohepatitis What are the symptoms of fatty liver disease Fatty liver is often called a 'silent' disease because it may present no symptoms in its early stages. You probably will not know you have it, unless it's diagnosed during tests carried out for another reason. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like These Are The Most Beautiful Women In The World Undo When the disease progresses, the following symptoms may appear. a dull or aching pain in the top right of the tummy (over the lower right side of the ribs) fatigue unexplained weight loss weakness What is the best exercise for fatty liver disease Dr. LeBrett has emphasized the importance of incorporating exercise into one's routine to improve and prevent certain conditions. 'One in four Americans will have fatty liver, and insulin resistance is a key driver in the development of non-alcoholic fatty liver,' the gastroenterologist said in a video shared on Instagram. She also emphasized the importance of controlling insulin resistance through exercise. 'Building muscle mass is one of the best ways to reduce insulin resistance and should be the priority at the gym with anyone with or at risk of fatty liver,' she said. When people think of exercise, especially as weight gain and obesity are linked to fatty liver disease, they jump on cardio. While cardio is beneficial in losing weight, the doctor emphasizes that building muscles is even more important. For that, she recommends weight-bearing exercises. 'Prioritizing weight-bearing exercise over cardio at the gym because increasing muscle mass is one of the best ways to prevent and improve fatty liver,' the doctor suggested. These exercises include walking, running, jumping, dancing, and using weights or resistance bands to perform exercises like squats, lunges, and push-ups. Matthew Perry Death Case: Doctor Mark Chavez Pleads Guilty Along with exercise, making some lifestyle changes, such as focusing on a balanced diet , can also help to improve and even reverse fatty liver disease. A balanced diet low in refined sugars and processed carbohydrates is ideal. Regular monitoring by a healthcare provider is essential to track progress and prevent complications.
